EUVIMEDEUVIMED entdecken
Open Access

Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients

Michael J Poellmann, Jiyoon Bu, Stanley Liu, Andrew Z Wang, Steven N Seyedin, Chandrikha Chandrasekharan, Heejoo Hong, YoungSoo Kim, Joseph M Caster, Seungpyo Hong

Biosensors and Bioelectronics · 2023

DOI: 10.1016/j.bios.2023.115117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023. Verfasst von Michael J Poellmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI, 53705, USA; Capio Biosciences, Inc., Madison, WI, 53719, USA and Capi…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Biosensing Techniques, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A highly sensitive, circulating tumor cell (CTC)-based liquid biopsy was used to monitor gastrointestinal cancer patients during treatment to determine if CTC abundance was predictive of disease recurrence. The approach used a combination of biomimetic cell rolling on recombinant E-selectin and dendrimer-mediated multivalent immunocapture at the nanoscale to purify CTCs from peripheral blood mononuclear cells. Due to the exceptionally high numbers of CTCs captured, a machine learning algorithm approach was developed to efficiently and reliably quantify abundance of immunocytochemically-labeled cells. A convolutional neural network and logistic regression model achieved 82.9% true-positive identification of CTCs with a false positive rate below 0.1% on a validation set. The approach was then used to quantify CTC abundance in peripheral blood samples from 27 subjects before, during, and following treatments. Samples drawn from the patients either prior to receiving radiotherapy or early in chemotherapy had a median 50 CTC ml-1 whole blood (range 0.6-541.6). We found that the CTC counts drawn 3 months post treatment were predictive of disease progression (p = .045). This approach to quantifying CTC abundance may be a clinically impactful in the timely determination of gastrointestinal cancer progression or response to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingBiosensing TechniquesGastrointestinal NeoplasmsHumansLeukocytes, MononuclearBiomarkersNanotechnologyBiomarkers, Tumor

Stichwörter der Autor:innen

Circulating tumor cellConvolutional neural networkGastrointestinal cancerLiquid biopsy

Substanzen

BiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI, 53705, USA; Capio Biosciences, Inc., Madison, WI, 53719, USA and Capio Biosciences Korea, Incheon, 21983 South Korea.
  • Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI, 53705, USA; Capio Biosciences, Inc., Madison, WI, 53719, USA and Capio Biosciences Korea, Incheon, 21983 South Korea; Department of Biologi…
  • Capio Biosciences, Inc., Madison, WI, 53719, USA and Capio Biosciences Korea, Incheon, 21983 South Korea.
  • Capio Biosciences, Inc., Madison, WI, 53719, USA and Capio Biosciences Korea, Incheon, 21983 South Korea; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
  • Department of Radiation Oncology, University of California Irvine, Irvine, CA, 92697, USA.
  • Department of Internal Medicine, University of Iowa, Iowa City, IA, 52242, USA.

Förderung

  • NCI NIH HHS
  • NIH

Zitieren

APA

Poellmann, M. J., Bu, J., Liu, S., Wang, A. Z., Seyedin, S. N., Chandrasekharan, C., Hong, H., Kim, Y., Caster, J. M., & Hong, S. (2023). Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115117

Vancouver

Poellmann MJ, Bu J, Liu S, Wang AZ, Seyedin SN, Chandrasekharan C, et al. Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors and Bioelectronics. 2023. doi:10.1016/j.bios.2023.115117

BibTeX
@article{Poellmann2023,
  author = {Poellmann, Michael J and Bu, Jiyoon and Liu, Stanley and Wang, Andrew Z and Seyedin, Steven N and Chandrasekharan, Chandrikha and Hong, Heejoo and Kim, YoungSoo and Caster, Joseph M and Hong, Seungpyo},
  title = {Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients},
  journal = {Biosensors and Bioelectronics},
  year = {2023},
  doi = {10.1016/j.bios.2023.115117}
}
Kostenlos starten →